anonymous
Guest
anonymous
Guest
This is true. If we don't buy you, your stock will plummet to about $25/share and you will be digested by Pfizer or Novartis. They are about the only ones, along with Merck, worse than us.
Get ready. Activity focus is almost upon you.
Those of you who like goal based incentive plans will do well ( and guess what, you are a loser who can't sell). Those of you who like to be left alone to sell, you will not last 6 months.
You have been warned.
You do realize that stock price is not just based upon how you feel about the company? Lol, idiot. The financials of Celgene have not changed significantly from pre-offer, and pre-offer the market was aware that the stock price undervalued the revenues. At $70/share any company with the means to make a deal for Celgene would do so, including those with no synergies to be gained. Look at the spreadsheets it’s a no brainer... you will NEVER see Celgene stock drop below $70